Pyrazole derivatives as cannabinoid receptor antagonists

Details Pyrazole derivatives as cannabinoid receptor antagonists Pyrazole derivatives as cannabinoid receptor antagonists

C - Chemistry, Metallurgy

07

D

C07D 231/14 (2006.01) A61K 31/415 (2006.01)

Patent

CA 2387892

Novel cannabimimetic pyrazole derivatives are presented which have preferentially high affinities for both of the cannabinoid CB1 or CB2 receptor sites. The improved receptor affinity makes these analogs useful as experimental tools for cannabinoid receptor studies as well as clinically useful agents in individuals and animals for treatment of memory deficits associated with aging or neurological diseases, as anti-obesity agents, as medications for schizophrenia and treatment of septic shock syndrome.

L'invention concerne de nouveaux dérivés de pyrazole cannabimimétiques qui possèdent de préférence des affinités élevées à l'égard des sites des récepteurs CB1 ou CB2 des cannabinoïdes. Cette affinité améliorée à l'égard des récepteurs rend les analogues utiles comme outils expérimentaux pour des études sur les récepteurs des cannabinoïdes et comme agents utiles d'un point de vue clinique, chez l'être humain et l'animal, pour le traitement de déficiences de la mémoire associées au vieillissement ou à des maladies neurologiques, comme agents anti-obésité, comme traitements de la schizophrénie et comme traitement du syndrome de choc septique.

Affiliated with

Also associated with

Rating

Pyrazole derivatives as cannabinoid receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrazole derivatives as cannabinoid receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazole derivatives as cannabinoid receptor antagonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1479512